Private Wealth Asset Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-906
Closed -$50.8K – 1007
2026
Q2
$50.8K Hold
906
– – ﹤0.01% 430
2026
Q1
$43.5K Sell
906
-6
-0.7% -$263 ﹤0.01% 451
2025
Q4
$35.2K Hold
912
– – ﹤0.01% 467
2025
Q3
$32.2K Hold
912
– – ﹤0.01% 459
2025
Q2
$32.9K Sell
912
-36
-4% -$1.19K ﹤0.01% 461
2025
Q1
$29.5K Buy
+948
New +$30K ﹤0.01% 448

Other funds holding RPRX

Private Wealth Asset Management's RPRX Position: Q3 2026 in Review

Private Wealth Asset Management sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 906 shares — an estimated $50.8K sold.

Private Wealth Asset Management first reported a position in RPRX in Q1 2025 and held it in 6 quarters. The position peaked at $50.8K in Q2 2026. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Private Wealth Asset Management reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Private Wealth Asset Management sold 906 Royalty Pharma shares in Q3 2026, an estimated $50.8K.
  • Private Wealth Asset Management first reported a position in Royalty Pharma in Q1 2025 and held it in 6 quarters.
  • Private Wealth Asset Management's Royalty Pharma position peaked at $50.8K in Q2 2026.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Private Wealth Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.